top of page

Weight Loss and more with GLP-1 Medications

8.png

At Rise Up Health, we are committed to helping you achieve your weight loss goals with cutting-edge treatments that are scientifically proven to work. One of the most effective options available today is GLP-1 medications, including Semaglutide and Tirzepatide,  These medications are transforming the landscape of weight management, offering real, sustainable results with many other potential benefits!

Explore the Power of Semaglutide, Tirzepatide, and Other GLP-1 Medications for Effective Weight Loss

GLP-1 (glucagon-like peptide-1) medications, first discovered in the 1980s, are a class of drugs that mimic a natural hormone in the body designed to regulate blood sugar levels and appetite. Now, Semaglutide, Tirzepatide, Wegovy™, and Zepbound™ are all GLP-1 medications that have shown remarkable benefits in weight loss by controlling hunger, reducing cravings, and increasing feelings of fullness.

These medications work by activating receptors in the brain that signal satiety, making it easier for individuals to reduce calorie intake and control their weight. They also help regulate insulin levels and improve blood sugar control, which is why they are effective for both weight loss and managing metabolic health.

9.png

How Do Semaglutide and Tirzepatide Help with Weight Loss?

  • Semaglutide: Available under the brand name Wegovy™, Semaglutide has become one of the most popular medications for weight loss. It works by reducing appetite and increasing satiety, making it easier to stick to a healthy eating plan. It has been shown in clinical studies to help individuals lose significant weight and maintain long-term weight loss.

  • Tirzepatide: A newer medication, Tirzepatide, available under the brand name Zepbound™ has shown even more promising results. It targets two receptors in the body, GLP-1 and GIP (glucose-dependent insulinotropic peptide), which help control appetite and metabolism. This dual action provides enhanced benefits for weight loss, often resulting in more significant weight reduction compared to other medications.

7.png

The History of GLP-1 Medications and Their Role in Weight Loss

In the 1980s, GLP-1 medications were initially developed for managing type 2 diabetes. Exenatide, was first approved by the FDA for weight loss in 2005 and researchers have continued to advanced this class of medication's safety profile and effectiveness over the past several years with a major milestone of Liraglutide (Saxenda™) in 2010. Researchers have found that these medications could not only improve blood sugar control but also aid in weight loss. As a result, drugs like Semaglutide and Tirzepatide became breakthrough treatments in the fight against obesity. 

In 2021, Wegovy™, a higher-dose version of Semaglutide, was approved by the FDA specifically for weight loss, and it quickly became one of the most widely prescribed GLP-1 medications. More recently, Zepbound™,  a higher-dose version of Tirzepatide, is a medication that works similarly and has emerged as an effective option for weight management and was approved by the FDA for weight loss in 2022.

These medications are designed to support long-term weight loss and can help individuals who have struggled with traditional diet and exercise plans. Whether used alone or in combination with other lifestyle changes, GLP-1 medications are a powerful tool in achieving sustainable weight loss.

Additional Possible Benefits of GLP-1 Medications

Aside from helping with weight loss Wegovy™ (Semaglutide) , and Zepbound™ (Tirzepatide) offer other health benefits:

  • Improved Blood Sugar Control: These medications help regulate blood sugar, reducing the risk of developing type 2 diabetes or improving control for those already diagnosed.

  • Heart Health: Research has shown that GLP-1 medications may help reduce the risk of cardiovascular disease, including lowering blood pressure and cholesterol levels.

  • Sustained Weight Loss: Unlike many fad diets, GLP-1 medications support long-term weight management, helping to prevent the cycle of weight loss and regain.

Other conditions with potential benefits that are emerging from research

Fatty Liver Disease (NAFLD/NASH)

Neurodegenerative Diseases (Alzheimer's and Parkinson's)

Polycystic Ovary Syndrome (PCOS)

Kidney Health

Cancer Prevention

Sleep Apnea

Auto-immune conditions

Chronic diarrhea, IBS, Chrohns, and other bowel conditions

5.png

REAL RESULTS

6.png

GLP-1 Weight Loss Benefits

Reduced waist circumference

Decreased risk of heart disease

Improvement in systolic blood pressure

Improved lipid blood levels

Lower HbA1C (A lab value used to monitor for Diabetes Type 2)

Decreased inflammation markers

Can improve PCOS (polycystic ovary syndrome) conditions

Who should not take GLP-1s

You should NOT take GLP1s if you are pregnant, breastfeeding, or plan on becoming pregnant in the next few months. You should also not take Semaglutide if you have a history of pancreatitis, multiple endocrine neoplasia, or medullary thyroid carcinoma. 

GLP-1s may cause GI upset, such as nausea, vomiting, diarrhea, constipation, and gas, but typically resolve over time in research studies. The compounded GLP-1s prescribed at Rise Up may be prescribed with alternative dosing schedules or compounded with B12, or other supplements, to reduce possible GI symptoms. Rise Up will also coach clients on the proper nutrition and eating habits to prevent GI symptoms. 

  • Instagram
  • Facebook

CONTACT US

DISCLAIMER: Some of the services provided have not been evaluated by the Food and Drug Administration. These products may not be intended to diagnose, treat, cure or prevent any disease. The material on this website is provided for informational purposes only and is not medical advice. Always consult your physician before beginning any therapy program. Any designations or references to therapies are for marketing purposes only and do not represent actual products. As an Amazon Associate we earn from qualifying purchases.

© 2025 Rise Up Health®, LLC. All Rights Reserved
bottom of page